The Washington Post–The cancer death rate in the United States fell 2.2 percent in 2017 — the biggest single-year drop ever reported — propelled by gains against lung cancer, the American Cancer Society said Wednesday.
The Verge–A new study reveals Google AI is often better at detecting breast cancer than actual doctors
National Institutes of Health – Studies in cell and animal models reveal insights into cancer cells’ vulnerability that could lead to new strategies against brain cancers.
The Guardian – The ultra-fine particles (UFPs) are produced by fuel burning, particularly in diesel vehicles, and higher exposures significantly increase people’s chances of getting the deadly cancer.
STAT / The Associated Press – The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it’s too soon to know if it will improve survival.
The New York Times – Just as computers can predict your shopping habits, researchers are using them to map the medical history of cancer patients to predict and treat the disease, and possibly to prevent it.
The Conversation – For the first time in the United States, a gene editing tool has been used to treat advanced cancer in three patients and showed promising early results in a pilot phase 1 clinical trial.
Live Science – Preliminary data from an innovative clinical trial suggests CRISPR could be safe for use in cancer therapy.
STAT – The Harnessing Organoids for Personalized Therapy (or HOPE) study, has enrolled 76 patients so far, and grown tumor organoids suitable for drug testing from a dozen of them.
BioPharma Dive – Food and Drug Administration leaders are concerned the agency won't be able to recruit and retain sufficient numbers of experts in fields that have undergone rapid scientific advances, such as cell and gene therapy or oncology.
The Conversation – Engineered nano-materials – objects about 10,000 times smaller than a grain of rice – can better deliver DNA into white blood cells called T-cells that defend us against cancer.
Bloomberg – In what US law-enforcement officials are calling one of the biggest health-care frauds in history, the Justice Department said that Medicare was fraudulently billed $2.1 billion after seniors were enticed to take unnecessary genetic tests for cancer.